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Abstract
Background: Researchers have developed several equations to predict glomerular filtration rate (GFR) in patients
with chronic kidney diseases (CKD). However, there are scarcely any studies performed to discern the best equation
to estimate GFR in patients with pure obstructive nephropathy. In present study, we assessed the suitability of six
prediction equations and compared their performance in eGFR evaluation for Chinese patients with obstructive
nephropathy.
Methods: A total of 245 adult patients with obstructive nephropathy were enrolled. We evaluated the performance
of the 3 Modification of Diet in Renal Disease equations (MDRD) (the original MDRD7, 7MDRD; the abbreviated
MDRD, aMDRD; and re-expressed abbreviated MDRD, re-aMDRD) and 3 Chronic Kidney Disease Epidemiology
Collaboration equations (CKD-EPI) (CKD-EPI equation based on creatinine alone, CKD-EPIcr; CKD-EPI equation based
on cystatin C alone, CKD-EPIcys; CKD-EPI equation based on combined creatinine-cystatin, CKD-EPIcr-cys). The
measured GFR (mGFR) by 99mTc-DTPA renal dynamic imaging method was used as the reference GFR.
Results: The mean age of the study population was 51.61 ± 14.17 and 131 were male (53.47 %). The mean
measured GFR was 66.54 ± 23.99 ml/min/1.73 m2. Overall, the CKD-EPIcr-cys equation gave the best performance
with the best correlation (R = 0.72) and agreement (−34.87, 40.83). CKD-EPIcr-cys equation also exhibited the highest
accuracy (69.39 %, P < 0.01) and diagnostic efficacy (ROCAUC = 0.874) with the smallest bias (2.98, P < 0.01). In the
subgroup of the lowest GFR, CKD-EPIcys equation exhibited the highest accuracy (52.69 %) and the smallest bias
(0.27). In the youngest age subgroup, CKD-EPIcys equation had the highest accuracy (71.64 %) and the smallest bias
(−1.24). In other subgroups stratified by GFR, age and gender, CKD-EPIcr-cys equation remained the best
performance.
Conclusion: The 3 CKD-EPI equations performed better than the 3 MDRD equations in estimating GFR in Chinese
obstructive nephropathy patients; while the CKD-EPI equation based on combined creatinine-cystatin C provided
the best estimation of GFR.
Keywords: Obstructive nephropathy, eGFR equation, Glomerular filtration rate
* Correspondence: xugang@tjh.tjmu.edu.cn; minhan@tjh.tjmu.edu.cn
1Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei
430030, China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Chen et al. BMC Nephrology  (2016) 17:150 
DOI 10.1186/s12882-016-0345-0
Background
Glomerular filtration rate (GFR) is an important indica-
tor of the filtering capacity of kidneys and is considered
the best overall index of renal function currently used
[1]. Estimated glomerular filtration rate (eGFR) is the
most important variable in the assessment of patients
with suspected or known kidney disease in clinical prac-
tice [2]. Traditional methods using renal clearances of
exogenous inulin, or other alternative exogenous
markers (such as iothalamate, EDTA, diethylene tria-
mine pentaacetic acid, and iohexol) can provide accurate
GFR evaluation [3]. However, these tests are time con-
suming and expensive [4], which limits the application
to monitor kidney function periodically. As an alterna-
tive, GFR estimating equations have been recommended
in clinical practice. In 1976, the first creatinine clearance
estimating equation - Cockcroft-Gault equation was de-
veloped [5]. From then on, researchers have developed
and calibrated a series of equations to provide conveni-
ent, time-saving and reproducible estimation of kidney
function, such as MDRD (Modification of Diet in Renal
Disease) and CKD-EPI (Chronic Kidney Disease Epi-
demiology Collaboration) equations etc. [6–9]. Recently,
the CKD-EPI group have developed new equations based
on serum cystatin C and combined creatinine-cystatin
C, which were shown to perform better than the previ-
ous CKD-EPI equation based on serum creatinine alone
[10]. However, the new equations have not been exter-
nally validated in a Chinese population yet. Obstructive
nephropathy refers to the renal disease caused by im-
paired urine flow or tubular fluid [11], which is taken as
one of the most common reasons for chronic kidney
disease (CKD) [12–14]. It can be caused by stone,
tumor, prostatic hyperplasia, etc. Long-term urinary
tract obstruction can lead to renal fibrosis [15]. The
pathological process of obstructive nephropathy is dif-
ferent from diffuse renal diseases initiated by immune
mechanism, in which the damage of both kidneys are
almost the same. However, obstructive nephropathy
often occurs unilaterally. Even if it happens bilaterally,
the degree of renal damage in the left and right kidneys
is not equal. The effects of urinary tract obstruction on
renal function must be considered both during and
after relief of obstruction and are greatly influenced by
whether the obstruction is unilateral or bilateral,acute
or chronic, partial or complete [14]. To the best of our
knowledge, no studies have validated these eGFR equa-
tions only in obstructive nephropathy patients. The
current study aimed at testing and comparing the esti-
mations of 6 commonly used eGFR equations (3 MDRD
Table 1 Equations to estimated GFR
eGFR method Equation
7MDRD 170 × (Scr)-0.999 × (Age)-0.176 × 0.762 (if female) × 1.180 (if black) × (BUN)-0.170 × (Alb)0.318
aMDRD 186 × (Scr)-1.154 × (Age)-0.203 × 0.742 (if female) × 1.212 (if black)
re-aMDRD 175 × (Scr)-1.154 × (Age)-0.203 × 0.742 (if female) × 1.212(if black)
CKD-EPIcr
Female; Scr≤ 0.7 mg/dl 144 × (Scr/0.7)−0.329 × 0.993Age [×1.159 if black]
Female; Scr > 0.7 mg/dl 144 × (Scr/0.7)−1.209 × 0.993Age [×1.159 if black]
Male; Scr≤ 0.9 mg/dl 141 × (Scr/0.9)−0.411 × 0.993Age [×1.159 if black]
Male; Scr > 0.9 mg/dl 141 × (Scr/0.9)−1.209 × 0.993Age [×1.159 if black]
CKD-EPIcys
Female or Male; Scys≤ 0.8 mg/dl 133 × (Scys/0.8)−0.499 × 0.996Age [×0.932 if female]
Female or Male; Scys > 0.8 mg/dl 133 × (Scys/0.8)−1.328 × 0.996Age [×0.932 if female]
CKD-EPIcr-cys
Female;
Scr≤ 0.7 mg/dl; Scys≤ 0.8 mg/dl 130 × (Scr/0.7)−0.248 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]
Scr≤ 0.7 mg/dl; Scys > 0.8 mg/dl 130 × (Scr/0.7)−0.248 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]
Scr > 0.7 mg/dl; Scys≤ 0.8 mg/dl 130 × (Scr/0.7)−0.601 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]
Scr > 0.7 mg/dl; Scys > 0.8 mg/dl 130 × (Scr/0.7)−0.601 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]
Male;
Scr≤ 0.9 mg/dl; Scys≤ 0.8 mg/dl 135 × (Scr/0.9)−0.207 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]
Scr≤ 0.9 mg/dl; Scys > 0.8 mg/dl 135 × (Scr/0.9)−0.207 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]
Scr > 0.9 mg/dl; Scys≤ 0.8 mg/dl 135 × (Scr/0.9)−0.601 × (Scys/0.8)−0.375 × 0.995Age [×1.08 if black]
Scr > 0.9 mg/dl; Scys > 0.8 mg/dl 135 × (Scr/0.9)−0.601 × (Scys/0.8)−0.711 × 0.995Age [×1.08 if black]
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equations and 3 CKD-EPI equations), including the
new developed CKD-EPI equation based on combined




This study was performed as a retrospective study using
resident patients diagnosed with obstructive nephropa-
thy who had underwent a GFR measurement by 99mTc-
diethylenetriamine penta-acetate (99mTc-DTPA) in
Tongji Hospital of Huazhong University of Science and
Technology (Wuhan, China) between May, 2012, and
October, 2013. To be included, the age had to be at least
18 years; the biochemical results, body weight, and
height had to be available from the patients’ case records
within 3 months of the GFR measurement. For patients
who had more than one GFR measurements, the first
one was used for analysis. Patients with acute kidney
injury, severe edema, pleural effusion or ascites,
Table 2 Characteristics of the study population
Variable Mean ± SD (n = 245) or n[%]
Male gender (n[%]) 131(53.5 %)
Age (years) 51.6 ± 14.2
Weight (kg) 62.0 ± 12.1
Height (cm) 163.9 ± 7.2
BMI (kg/m2) 23.0 ± 3.6
BSA (m2) 1.7 ± 0.2
Serum creatinine (mg/dl) 1.2 ± 1.1
Serum cystatin C (mg/l) 1.4 ± 0.7
Serum urea (mg/dl) 18.0 ± 10.8
Serum albumin (g/dl) 3.7 ± 0.5
Measured GFR (ml/min/1.73 m2) 67 ± 24
BMI (kg/m2) = body weight (kg) / height (m)2
BSA (m2) = body weight (kg)0.425 × height (cm)0.725 × 0.007184
BMI body mass index, BSA body surface area, GFR glomerular filtration rate
Fig. 1 Correlation between measured GFR (mGFR) and estimated GFR (eGFR) using 6 different prediction equations (univariate linear regression
model was used, the solid line represents the regression line)
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malnutrition, amputation or skeletal muscle atrophy,
heart failure or ketoacidosis were excluded. Patients who
were taking cimetidine, trimethoprim or those who were
on any kind of renal replacement therapy were also ex-
cluded [16]. Finally, a total of 245 individuals were en-
rolled in the present study.
GFR measurements
The measurement of GFR was performed using 99mTc-
DTPA renal dynamic imaging by Ifinia Hawkeye 4 SPECT
(GE Healthcare, USA). The identical standard measuring
method was as follows: patients were hydrated with
300 ml of water 30mins before the examination. Radio-
activity of the syringe containing 99mTc-DTPA (provided
by Jiangsu Atom Medicine Research Institute, Jiangyuan
Pharmaceutical Factory) was counted before injection.
And then each of the patients was given a bolus of intra-
venous injection of approximately 185 MBq DTPA into
the forearm. After that, the dynamic renal flow images
were collected immediately using the XelerisTM3 Func-
tional Imaging Workstation (GE Healthcare Biosciences,
Piscataway, NJ, USA). The post-injection syringe was
also counted. Thus the difference of the syringe’s radio-
activity between pre- and post-injection was defined as
the exact dosage of administered 99mTc-DTPA. The
calculation of GFR values was done by the XelerisTM3
Functional Imaging Workstation automatically accord-
ing to the modified Gate’s equation [17, 18]. The mea-
sured GFR (mGFR) was standardized by body surface
area (BSA) [15].
Fig. 2 Curves of Receiver Operating Characteristics analysis for the diagnostic ability of CKD-EPIcr-cys equation (solid-line curve) versus other 5
equations (dotted-line curves). The values of the area under the curve were listed in Table 3
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Biochemical measurements
Serum creatinine was measured by Roche enzymatic
assay (Shanghai Roche Diagnostic Products Co., Ltd,
China). Cystatin C was determined by article-enhanced
immunoturbidimetry assay (Beijing Leadman Biomedical
Co., Ltd, China). All of the fasting blood samples were
assayed on a Roche automatic biochemical analyser
(cobas 8000 modular analyzer series, Roche Diagnostics
Operations, Inc, USA). For patients who had multiple
check results, the one nearest date of GFR measurement
was used.
Estimation of GFR
Estimated GFR (eGFR) were calculated by 6 different
equations; including 3 MDRD equations (the original
MDRD7 [6], the abbreviated MDRD equation [7] and the
reexpressed abbreviated MDRD [8] equation, hereafter
referred to as the 7MDRD equation, aMDRD equation
and re-aMDRD equation respectively); and 3 CKD-EPI
equations (CKD-EPI equation based on creatinine alone
[9], CKD-EPI equation based on cystatin C alone, and
CKD-EPI equation based on combined creatinine-
cystatin C [10], hereafter referred to as the CKD-
EPIcr equation, CKD-EPIcys equation, and CKD-
EPIcr-cys equation respectively). All the equations
were all listed in Table 1.
Statistical analysis
All statistical analysis were performed in SPSS statistical
software, version 19.0 for Windows (SPSS, Chicago, IL,
USA). Population characteristics were tested with t test,
and all data were presented as means ± SD. Body surface
area (BSA) was calculated as follows [19]:
BSA=(bodyweight0.425[inkg]×height0.725[incm])×0.007184.
To compare the performance of the equations, Pearson
correlation analysis and linear regression were applied to
compare the correlation between measured GFR and
estimated GFR (Pearson coefficient R was calculated)
and bias, precision, and accuracy were also calcu-
lated as recommended [20, 21]. Bland-Altman plots
were used to study the relation between the GFR
and measurement error, we assessed the bias as well
as the limits of agreement (calculated as the bias
plus or minus 1.96 times of the precision) [22]. We
applied area under receiver operating characteristic
(ROCAUC) curve to describe the diagnostic efficacy
of the equations. Paired t test and McNemar test
were respectively used to test the difference in bias
and accuracy between the estimated equations. In
addition, bias, precisions and accuracies were also
analyzed within the stratifications of GFR, gender,
and age, in order to assess the influences of these
variables in subgroups. The cutoffs used for GFR
stratification were <60, 60 to 90, and >90 ml/min/
1.73 m2, and for age, it were <45, 45 to 60, and
>60 years.
Results
Characteristics of the population
In total, 245 Chinese patients with obstructive nephropathy
were included in this study, including 131 males and 114 fe-
males with a mean age of 51.61 ± 14.17 years. The average
value of the measured GFR was 66.54 ± 23.99 ml/min/
1.73 m2. Detailed laboratory measurements and basic char-
acteristics of the study population were presented in Table 2.
Association and agreement between estimated GFR and
measured GFR
The overall relationships between measured and esti-
mated GFR values were presented in Fig. 1. All of
the six prediction equations correlated well with the
measured GFR (p < 0.001) (Fig. 2). The Pearson cor-
relation coefficients (R) varied from 0.681 to 0.720,
and CKD-EPIcr-cys equation showed the best correl-
ation (R = 0.720, shown in Table 3). CKD-EPIcr-cys
equation also gave the highest accuracy (P < 0.01), the
smallest bias (P < 0.01) (Table 4) and the best diag-
nostic efficiency (ROCAUC = 0.847, p < 0.001, Table 3).
Furthermore, description of the agreement between esti-
mated and measured GFR were shown in Fig. 3. CKD-
EPIcr-cys equation presented the best agreement with the
measured GFR (95%CI [−34.87, 40.83]).
Table 4 Performance of the equations
Equation Bias Precision Accuracy(%)
≤15 % ≤30 % ≤50 %
7MDRD 12.14** 23.33** 34.29** 57.55** 78.37**
aMDRD 14.77** 24.65** 29.80** 53.47** 74.69**
re-aMDRD 9.96** 23.33** 32.65** 60.41** 80.41**
CKD-EPIcr 13.51** 21.58** 30.61** 53.88** 78.78**
CKD-EPIcys −4.24** 20.32** 38.78** 67.76 88.16
CKD-EPIcr-cys 2.98 19.31 44.49 69.39 87.35
Bias was the mean difference between estimated and measured GFR. Precision
was the SD of this difference. Accuracy was the percentage of results
deviating by ≤ 15, 30 and 50%from the meaured GFR. ** P < 0.01 versus the
CKD-EPIcr-cys equation
Table 3 Diagnostic values of the equations
Equation R ROCAUC Sensitivity
7MDRD 0.681 0.816 0.72
aMDRD 0.672 0.802 0.71
re-aMDRD 0.672 0.802 0.71
CKD-EPIcr 0.696 0.816 0.72
CKD-EPIcys 0.675 0.833 0.73
CKD-EPIcr-cys 0.720 0.847 0.74
R: coefficient of relationship with measured GFR
ROCAUC: area under receiver operating characteristic curve
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Performance of equations in subgroups
In subgroups stratified by GFR, CKD-EPIcys equation
exhibited the highest accuracy (52.69 %) and the smallest
bias (0.27) in the group of the lowest GFR, while CKD-
EPIcys equation and CKD-EPIcr-cys equation had an
equally accuracy in patients with a GFR between 60 and
90 ml/min/1.73 m2. In the group of the highest GFR, CKD-
EPIcr-cys equation remained the best, but both of them
had larger bias in this group. For subgroups stratified
by age, CKD-EPIcys equation had the best perform-
ance in the group of the youngest patients, with the
highest accuracy (71.64 %) and the lowest bias
(−1.24); in the other 2 age groups, CKD-EPIcr-cys
equation still did the best. The bias of all the 6
equations was larger in women than in men. For
both genders, the highest accuracy was reached by
CKD-EPIcr-cys equation. Mean bias and precision
for subgroups were presented in Fig. 4, and the
values were shown in Table 5. In general, the 3
CKD-EPI equations provided better performance
than the 3 MDRD equations, while CKD-EPIcr-cys
equation gave the best correlation, the highest accur-
acy (P < 0.01) and diagnostic efficacy, and also the
smallest bias (P < 0.01).
Discussion
Periodic monitoring of kidney function by a conveni-
ent and accurate method is necessary for early diag-
nosis of renal disease, individualized treatment and
prognosis evaluation in clinical practice [3]. This
pragmatic study was performed to compare 6 rela-
tively popular GFR estimation equations in 245 Chin-
ese patients with obstructive nephropathy, in order to
test the applicability of the equations to pure ob-
structive nephropathy. As we expected, all these 6
eGFR equations were validated to estimate glomerular
filtration function in obstructive nephropathy patients,
and CKD-EPIcr-cys equation was more positively
Fig. 3 Bland-Altman plots of the estimated and measured GFR. eGFR - mGFR represents the difference between the estimated GFR (eGFR) and
the measured GFR (mGFR). A positive difference indicates an overestimation by the equation, whereas a negative difference indicates an
underestimation. The solid lines indicate the mean difference; the dashed lines indicate the lines of agreement, calculated as the mean difference
±1.96 SD of this difference
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correlated with the 99mTc-DTPA GFR and had higher
accuracy, even if there is the difference of pathogen-
esis, pathological and physiological changes and prog-
nosis between obstructive nephropathy and diffuse
renal diseases. Of all the 6 equations, the 3 CKD-EPI
equations are generally more accurate than the 3
MDRD equations. Among the 3 MDRD equations,
aMDRD equation is simpler to use than 7MDRD
equation because it does not require inclusion of
serum urea nitrogen and albumin concentration. Ex-
clusion of these variables may also make the equation
less susceptible to conditions in which serum urea ni-
trogen or albumin is strongly influenced by factors
other than GFR. However, in our study, aMDRD
equation did not perform better than 7MDRD equa-
tion. It was probably because of the difference in the
serum creatinine measuring assay, which was assayed
by the kinetic alkaline picrate in the original study of
7MDRD equation [6]. While in our study, it was mea-
sured by Roche enzymatic assay, which was more
comparable to isotope dilution mass spectrometry
(IDMS) -assigned values [8]. This may also explain
the better performance of re-aMDRD equation, be-
cause re-aMDRD equation was developed by stand-
ardizing serum creatinine levels to an assay traceable
to IDMS [8, 23]. The Kidney Disease Improving Glo-
bal Outcomes (KDIGO) 2012 Clinical Practice Guide-
line for the Evaluation and Management of Chronic
Kidney Disease recommended use of the 2009 CKD-
EPI equation (CKD-EPIcr) instead of the MDRD
study equation to estimate GFR from serum creatin-
ine. And they suggest to use the 2012 CKD-EPI
equations for GFR estimation (CKD-EPIcys, CKD-
EPIcr-cys) [24]. It has already been validated that the
2012 CKD-EPI equations are applicable for Chinese
population [25]. And our study results are also con-
sistent with the guideline. There are several possible
reasons for the best performance of the CKD-EPIcr-
cys equation. Firstly, compared with MDRD equa-
tions, development and validation of the 3 CKD-EPI
Fig. 4 Comparison of the mean bias and precision over subgroups stratified by gender, age, and measured GFR. The mean bias was calculated as
the mean of the differences between the estimated and measured GFR per subgroup, whereas the precision was the SD of this difference
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Table 5 Performance of the equations in subgroups
Variable Subgroup 7MDRD aMDRD re-aMDRD CKD-EPIcr CKD-EPIcys CKD-EPIcr-cys
B P A(30 %) B P A(30 %) B P A(30 %) B P A(30 %) B P A(30 %) B P A(30 %)
GFR
(ml/min/1.73 m2)
<60 13.83 24.39 40.86 15.20 25.13 39.78 11.82 23.57 43.01 14.88 23.90 37.63 0.27 19.33 52.69 5.49 19.83 51.61
60–90 13.69 19.51 64.86 16.84 21.39 59.46 11.46 20.19 68.47 16.92 18.21 54.95 −2.15 19.45 76.58 5.90 17.64 76.58
>90 4.08 28.73 75.61 8.18 30.63 68.29 1.68 28.91 78.05 1.19 20.60 87.80 −20.11 17.39 78.05 −10.62 16.94 90.24
Age
(year)
<45 17.39 28.23 55.22 18.48 29.66 50.75 12.87 27.96 61.19 19.25 24.86 47.76 −1.24 22.72 71.64 6.92 22.09 64.18
45–60 10.48 21.54 59.29 13.76 23.13 56.64 8.92 21.91 64.60 12.44 20.14 56.64 −4.66 19.96 72.57 2.31 18.00 75.22
>60 9.61 20.04 12.70 12.70 21.28 50.77 8.77 20.39 52.31 9.45 19.39 55.38 −6.60 18.16 55.38 0.07 18.05 64.62
Gender Male 11.80 23.19 64.12 14.53 24.31 56.49 9.83 22.85 64.12 12.24 20.12 59.45 −4.30 20.33 67.18 2.49 18.47 73.28
Female 12.52 23.59 50.00 15.05 25.13 50.00 10.11 23.96 56.14 14.97 23.15 47.37 −4.17 20.40 68.42 3.54 20.30 64.91
Number of obstructed kidney Unilateral 15.47 23.16 58.43 18.4 24.19 54.82 13.17 23.01 63.86 16.32 20.21 57.23 −2.74 19.87 72.29 5.29 18.59 74.70
Bilateral 5.14 22.24 55.7 7.15 23.99 50.63 3.22 22.66 53.16 7.61 23.27 46.84 −7.38 21.03 58.23 −1.88 20.00 58.23
Disease duration ≥3 months 11.19 25.75 60.61 13.52 26.83 54.55 8.62 25.48 65.91 16.13 20.43 47.79 −3.13 18.47 73.45 4.65 17.13 70.80
<3 months 13.24 20.2 53.98 16.24 21.73 52.21 11.53 20.54 53.98 11.28 22.36 59.09 −5.19 21.81 62.88 1.55 20.96 68.18













equations were conducted with large databases in-
clude participants with diverse clinical characteristics,
with or without kidney disease, and across a wide
range of measured GFR, thus allowing more general
applicability than MDRD equations [9, 10]. Secondly,
in the CKD-EPI equations, serum creatinine values
are stratified according to gender and different cutoff
values. However, in MDRD equations, there is no
stratification. Thirdly, in comparison with MDRD,
CKD-EPIcr-cys was expected to provide a more ac-
curate estimated GFR, as cystatin C is a better glom-
erular filtration maker [26–28]. However, in our
study, the CKD-EPI equation based on cystatin C
alone was not more accurate than the creatinine esti-
mates, suggesting that unmeasured and largely un-
known non-GFR determinants of cystatin C are
similar in magnitude to those of creatinine, which is
consistent with the original publication [10]. Never-
theless, in subgroups stratified by age and gender,
CKD-EPIcys equation exhibited higher accuracy than
CKD-EPIcr equation. Thus, we did confirm the advan-
tage of the cystatin C-based equation at less subject to the
effects of age and gender than creatinine-based equa-
tions [8]. This study has its limitations. First, because
of the retrospective data collection, most measure-
ments of serum creatinine and GFR were not con-
ducted on the same day. The daily changing
creatinine and GFR may influence the results to some
extent. Second, the measurement of serum cystatin C
was not calibrated to standard method as did in the
original study. Third, the sample size was relatively
small, the validation of the 2012 CKD-EPI equations
in pure obstructive nephropathy population can not
represent the whole CKD population.
Conclusion
In conclusion, the 3 CKD-EPI equations performed bet-
ter than the 3 MDRD equations in estimating GFR in
Chinese obstructive nephropathy patients; while among
the 3 CKD-EPI equations, the CKD-EPI equation based
on combined creatinine-cystatin C provided the best es-
timation of GFR. Our data suggested that the CKD-EPI
equation based on combined creatinine-cystatin C
should be widely used in general clinical practice to
assess kidney function for obstructive nephropathy
patients in China.
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